Top Core and Group Health Stories
AstraZeneca joins Pfizer in TrumpRx initiative
By Allison BellAstraZeneca has now become the second largest drug maker to agree to offer consumers deep discounts through direct-sales arrangements.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
AstraZeneca has now become the second largest drug maker to agree to offer consumers deep discounts through direct-sales arrangements.